{"entity":{"type":"insider","cik":"0001264698","url":"/insider/0001264698","json_url":"/insider/0001264698.json","name":"JOHNSON PAUL H","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":3,"first":"2006-10-06","last":"2007-09-07","span_basis":"filed_date"},"name_variants":[{"name":"JOHNSON PAUL H","source":"filing","n_filings":3,"first_seen":"2006-10-06","last_seen":"2007-09-07"}],"transactions":[{"id":8137954,"accession":"0001209191-07-052515","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-07-052515","line_url":"/filing/0001209191-07-052515","is_derivative":false,"issuer_cik":"0000737207","issuer_name":"NASTECH PHARMACEUTICAL CO INC","issuer_ticker":"NSTK","issuer_name_source":null,"issuer_url":"/issuer/0000737207","owner_cik":"0001264698","owner_name":"JOHNSON PAUL H","owner_display_name":"JOHNSON PAUL H","owner_url":"/insider/0001264698","role":"Officer (Sr VP of R&D, CSO)","role_mark":"O","role_mark_label":"Officer (Sr VP of R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP of R&D, CSO","security_title":"Nastech Pharmaceutical Company Inc Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47200.0,"shares_display":"47,200","price_per_share":14.3002,"price_display":"14.30","price_state":"stated","total_value":674969.44,"total_display":"674,969.44","total_whole":"674,969","shares_owned_after":29494.0,"shares_owned_after_display":"29,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-06","filed_date":"2007-09-07","scope":"insider","n_lines":2},{"id":7380174,"accession":"0001209191-07-050200","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-07-050200","line_url":"/filing/0001209191-07-050200#line-6","is_derivative":false,"issuer_cik":"0000737207","issuer_name":"NASTECH PHARMACEUTICAL CO INC","issuer_ticker":"NSTK","issuer_name_source":null,"issuer_url":"/issuer/0000737207","owner_cik":"0001264698","owner_name":"JOHNSON PAUL H","owner_display_name":"JOHNSON PAUL H","owner_url":"/insider/0001264698","role":"Officer (Sr VP of R&D, CSO)","role_mark":"O","role_mark_label":"Officer (Sr VP of R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP of R&D, CSO","security_title":"Nastech Pharmaceutical Company Inc Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":14.3036,"price_display":"14.30","price_state":"stated","total_value":15733.96,"total_display":"15,733.96","total_whole":"15,734","shares_owned_after":19845.0,"shares_owned_after_display":"19,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-23","filed_date":"2007-08-23","scope":"insider"},{"id":7380170,"accession":"0001209191-07-050200","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-07-050200","line_url":"/filing/0001209191-07-050200#line-4","is_derivative":false,"issuer_cik":"0000737207","issuer_name":"NASTECH PHARMACEUTICAL CO INC","issuer_ticker":"NSTK","issuer_name_source":null,"issuer_url":"/issuer/0000737207","owner_cik":"0001264698","owner_name":"JOHNSON PAUL H","owner_display_name":"JOHNSON PAUL H","owner_url":"/insider/0001264698","role":"Officer (Sr VP of R&D, CSO)","role_mark":"O","role_mark_label":"Officer (Sr VP of R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP of R&D, CSO","security_title":"Nastech Pharmaceutical Company Inc Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20558.0,"shares_display":"20,558","price_per_share":14.3,"price_display":"14.30","price_state":"stated","total_value":293979.4,"total_display":"293,979.40","total_whole":"293,979","shares_owned_after":19606.0,"shares_owned_after_display":"19,606","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-22","filed_date":"2007-08-23","scope":"insider"},{"id":7380166,"accession":"0001209191-07-050200","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-050200","line_url":"/filing/0001209191-07-050200#line-2","is_derivative":false,"issuer_cik":"0000737207","issuer_name":"NASTECH PHARMACEUTICAL CO INC","issuer_ticker":"NSTK","issuer_name_source":null,"issuer_url":"/issuer/0000737207","owner_cik":"0001264698","owner_name":"JOHNSON PAUL H","owner_display_name":"JOHNSON PAUL H","owner_url":"/insider/0001264698","role":"Officer (Sr VP of R&D, CSO)","role_mark":"O","role_mark_label":"Officer (Sr VP of R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP of R&D, CSO","security_title":"Nastech Pharmaceutical Company Inc Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":14.5,"price_display":"14.50","price_state":"stated","total_value":56550.0,"total_display":"56,550.00","total_whole":"56,550","shares_owned_after":12106.0,"shares_owned_after_display":"12,106","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-21","filed_date":"2007-08-23","scope":"insider"},{"id":5570987,"accession":"0001209191-06-054139","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-054139","line_url":"/filing/0001209191-06-054139#line-1","is_derivative":false,"issuer_cik":"0000737207","issuer_name":"NASTECH PHARMACEUTICAL CO INC","issuer_ticker":"NSTK","issuer_name_source":null,"issuer_url":"/issuer/0000737207","owner_cik":"0001264698","owner_name":"JOHNSON PAUL H","owner_display_name":"JOHNSON PAUL H","owner_url":"/insider/0001264698","role":"Officer (Sr VP of R&D, CSO)","role_mark":"O","role_mark_label":"Officer (Sr VP of R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP of R&D, CSO","security_title":"Nastech Pharmaceutical Co. Inc. Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":661.0,"shares_display":"661","price_per_share":15.54,"price_display":"15.54","price_state":"stated","total_value":10271.94,"total_display":"10,271.94","total_whole":"10,272","shares_owned_after":10404.0,"shares_owned_after_display":"10,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-10-05","filed_date":"2006-10-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000737207","name":"NASTECH PHARMACEUTICAL CO INC","url":"/issuer/0000737207","role":"Officer (Sr VP of R&D, CSO)","n_filings":3,"first_seen":"2006-10-06","last_seen":"2007-09-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001264698","retrieved_at":"2026-08-22T09:06:14+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}